Elezanumab, a clinical stage human monoclonal antibody that selectively targets repulsive guidance molecule A to promote neuroregeneration and neuroprotection in neuronal injury an...

by Lili Huang, Emma Fung, Sahana Bose, Andreas Popp, Preethne Böser, John Memmott, Yuliya A. Kutskova, Renee Miller, Edit Tarcsa, Corinna Klein, Geertruida M. Veldman, Bernhard K. Mueller, Yi-Fang Cui
Published 2021-11-01